APAC Healthcare Weekly (Jan 19)- Samsung Biologics, Daiichi Sankyo, Eisai, Sun Pharma, Biocon
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
541 Views
EQD | Hong Kong Single Stock Options Weekly January 06 – 10
Investors remain calm despite majority of optionable stocks declining, with preference for Calls over Puts; Tencent dominates option trading...
245 Views
Wuxi XDC Placement - A Repeat of Biologics Placement Saga, Last Deal Did Well
WuXi AppTec (2359 HK) aims to raise around US$150m via selling around 3% stake in WuXi XDC Cayman (2268 HK). It has sold earlier in Nov 24 as well.
720 Views
EQD | Hong Kong Single Stock Options Weekly Dec 30 – Jan 03
Single stock put volumes are on the rise, pushing the put call ratio over 1 for the first time since November. Heavy put trading in financial...
287 Views
APAC Healthcare Weekly (Jan 5)- Beigene, Innovent Biologics, CSPC Pharma, Hutchmed, Yuhan, Lupin
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
477 Views